Generalized Anxiety Disorder: Between Now and DSM-V

被引：7

作者：

Allgulander, Christer ^{[1
]}

机构：

[1] Karolinska Univ Hosp, Sect Psychiat, Karolinska Inst, Dept Clin Neurosci, SE-14186 Huddinge, Sweden

来源：

PSYCHIATRIC CLINICS OF NORTH AMERICA | 2009年 / 32卷 / 03期

关键词：

Anxiety disorders; Classification; Anti-anxiety agents; Antidepressive agents; Pharmacology; Generalized anxiety disorder; GAD; DSM-V; OBSTRUCTIVE PULMONARY-DISEASE; LONG-TERM TREATMENT; DOUBLE-BLIND; MAJOR DEPRESSION; OLDER-ADULTS; PRIMARY-CARE; MOOD DISORDER; SOCIAL PHOBIA; CO-MORBIDITY; LATE-LIFE;

D O I：

10.1016/j.psc.2009.05.006

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This article presents the current evidence base for pharmacotherapy of generalized anxiety disorder (GAD) and an update on the phenomenology of GAD and its association with other psychiatric and somatic conditions. It discusses nosological issues and suggests ways to improve recognition, treatment, and care for patients who have GAD.

引用

页码：611 / +

页数：19

共 101 条

[1] Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial
Allgulander, C.
Jorgensen, T.
Wade, A.
Francois, C.
Despiegel, N.
Auquier, P.
Toumi, M.
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (10) : 2543 - 2549
[2] WCA-recommendations for the long-term treatment of generalized anxiety disorder
Allgulander, C
Bandelow, B
Hollander, E
Montgomery, SA
Nutt, DJ
Okasha, A
Pollack, MH
Stein, DJ
Swinson, RP
[J]. CNS SPECTRUMS, 2003, 8 (08) : 53 - 61
[3] ALLGULANDER C, 1994, ARCH GEN PSYCHIAT, V51, P708
[4] Prevention of relapse in generalized anxiety disorder by escitalopram treatment
Allgulander, Christer
Florea, Ioana
Huusom, Anna K. Trap
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 (05) : 495 - 505
[5] Anxiety and poor glycemic control: A meta-analytic review of the literature
Anderson, RJ
Grigsby, AB
Freedland, KE
de Groot, M
McGill, JB
Clouse, RE
Lustman, PJ
[J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2002, 32 (03) : 235 - 247
[6] The generalized anxiety spectrum: prevalence, onset, course and outcome
Angst, Jules
Gamma, Alex
Baldwin, David S.
Ajdacic-Gross, Vladeta
Roessler, Wulf
[J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2009, 259 (01) : 37 - 45
[7] Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors
Arnold, Staci D.
Forman, Leslie M.
Brigidi, Bart D.
Carter, Karen E.
Schweitzer, Holly A.
Quinn, Heather E.
Guill, A. Bebe
Herndon, James E., II
Raynor, Renee H.
[J]. NEURO-ONCOLOGY, 2008, 10 (02) : 171 - 181
[8] World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision
Bandelow, Borwin
Zohar, Joseph
Hollander, Eric
Kasper, Siegfried
Moeller, Hans-Juergen
Allgulander, Christer
Ayuso-Gutierrez, Jose
Baldwin, David
Bunevicius, Robertas
Cassano, Giovanni
Fineberg, Naomi
Gabriels, Loes
Hindmarch, Ian
Kaiya, Hisanobu
Klein, Donald F.
Lader, Malcolm
Lecrubier, Yves
Lepine, Jean-Pierre
Liebowitz, Michael R.
Lopez-Ibor, Juan Jose
Marazziti, Donatella
Miguel, Euripedes C.
Oh, Kang Seob
Preter, Maurice
Rupprecht, Rainer
Sato, Mitsumoto
Starcevic, Vladan
Stein, Dan J.
van Ameringen, Michael
Vega, Johann
[J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2008, 9 (04) : 248 - 312
[9] Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients
Bankier, Bettina
Barajas, Justine
Martinez-Rumayor, Abelardo
Januzzi, James L.
[J]. EUROPEAN HEART JOURNAL, 2008, 29 (18) : 2212 - 2217
[10] Barlow DH., 2002, Anxiety and its disorders: the nature and treatment of anxiety and panic, V2 ed.

← 1 2 3 4 5 6 7 8 9 10 →